Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.1.02000
European Journal of Endocrinology, Vol 153, Issue 4, 545-549
Copyright © 2005 by European Society of Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow An erratum has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vestergaard, E T
Right arrow Articles by Jorgensen, J O L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vestergaard, E T
Right arrow Articles by Jorgensen, J O L

CLINICAL STUDY

Effects of GH replacement therapy in adults on serum levels of leptin and ghrelin: the role of lipolysis

E T Vestergaard, T K Hansen, S Nielsen, N Moller, J S Christiansen and J O L Jorgensen

Medical Department M (Endocrinology and Diabetes), Aarhus University Hospital, Dk-8000 Aarhus C, Denmark

(Correspondence should be addressed to E T Vestergaard; Email: etv{at}dadlnet.dk)

Objective: The regulation and function of systemic ghrelin levels appear to be associated with food intake and energy balance rather than GH. Since GH, in turn, acutely induces lipolysis and insulin resistance in skeletal muscle, we aimed to study the isolated and combined effects of GH, free fatty acids (FFAs) and insulin sensitivity on circulating ghrelin levels in human subjects.

Design: Seven GH-deficient patients (aged 37 ± 4 years (mean ± S.E.)) were studied on four occasions in a 2 x 2 factorial design with and without GH substitution and with and without administration of acipimox, which lowers FFA levels by inhibition of the hormone-sensitive lipase, in the basal state and during a hyperinsulinemic euglycemic clamp.

Results: Serum FFA levels decreased with acipimox administration irrespective of GH status. The GH-induced reduction in insulin sensitivity was countered by acipimox. Fasting ghrelin levels decreased insignificantly during GH administration alone, but were reduced by 33% during co-administration of GH and acipimox (Aci) (in ng/l): 860 ± 120 (–GH – Aci), 711 ± 130 (–GH + Aci), 806 ± 130 (+GH – Aci), 574 ± 129 (+GH + Aci), P < 0.01. The clamp was associated with a further, moderate lowering of ghrelin. GH and acipimox induced a reciprocal 25% increase in serum leptin levels (µg/l): 11.2 ± 4.4 (–GH – Aci), 11.7 ± 4.4 (–GH + Aci), 11.5 ± 4.4 (+GH – Aci), 13.9 ± 4.2 (+GH + Aci), P = 0.005.

Conclusion: Our data suggest that antilipolysis via suppression of the hormone-sensitive lipase in combination with GH administration is associated with significant and reciprocal changes in ghrelin and leptin.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
B. P. Hauffa, K. Haase, I. M. Range, N. Unger, K. Mann, and S. Petersenn
The Effect of Growth Hormone on the Response of Total and Acylated Ghrelin to a Standardized Oral Glucose Load and Insulin Resistance in Children with Prader-Willi Syndrome
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 834 - 840.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
L. C Gormsen, J. Gjedsted, S. Gjedde, E. T. Vestergaard, J. S Christiansen, J. O. Jorgensen, S. Nielsen, and N. Moller
Free fatty acids decrease circulating ghrelin concentrations in humans.
Eur. J. Endocrinol., May 1, 2006; 154(5): 667 - 673.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Bowen, M. Noakes, C. Trenerry, and P. M. Clifton
Energy Intake, Ghrelin, and Cholecystokinin after Different Carbohydrate and Protein Preloads in Overweight Men
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1477 - 1483.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 European Society of Endocrinology.